Clinical determinants of the modified incremental step test in adults with non-cystic fibrosis bronchiectasis
Open Access
- 16 January 2024
- journal article
- research article
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (1) , e20230230
Abstract
Objectives: This study primarily aimed to investigate the clinical determinants of the Modified Incremental Step Test (MIST) in adults with non-cystic fibrosis bronchiectasis (NCFB). A secondary objective was to compare the cardiopulmonary responses after the MIST and Incremental Shuttle Walk Test (ISWT), two commonly adopted symptomlimited maximum field tests in chronic respiratory diseases. Methods: Forty- six patients with clinically stable bronchiectasis participated in this cross-sectional study. MIST and ISWT were performed to determine exercise capacity, while disease severity, fatigue, and quality of life were assessed using the Bronchiectasis Severity Index (BSI), the Fatigue Severity Scale (FSS), and St. George's Respiratory Questionnaire (SGRQ), respectively. Quadriceps muscle strength was evaluated using a hand-held dynamometer, walking speed with a wireless inertial sensing device, and the level of physical activity (steps/day) with a pedometer. Results: The BSI score, quadriceps muscle strength, daily step count, and the SGRQ total score explained 61.9% of the variance in the MIST (p < 0.001, R2 = 0.67, AR2 = 0.619). The BSI score (r = -0.412, p = 0.004), quadriceps muscle strength (r = 0.574, p = 0.001), daily step count (r = 0.523, p < 0.001), walking speed (r = 0.402, p = 0.006), FSS score (r = -0.551, p < 0.001), and SGRQ total score (r = - 0.570, p < 0.001) correlated with the MIST. The patients achieved higher heart rates (HR), HR%, desaturation, dyspnea, and leg fatigue in the MIST compared to the ISWT (p < 0.05). Conclusions: Disease severity, quadriceps muscle strength, physical activity level, and quality of life were determinants of MIST. The advantages of the MIST, including higher cardiopulmonary response than ISWT and greater portability, which facilitates its use in various settings, make MIST the preferred choice for investigating symptom-limited exercise capacity in patients with NCFB.Keywords
This publication has 39 references indexed in Scilit:
- Reference values for the incremental shuttle walking testRespiratory Medicine, 2012
- Extrapulmonary features of bronchiectasis: muscle function, exercise capacity, fatigue, and health statusMultidisciplinary Respiratory Medicine, 2012
- How many steps/day are enough? for adultsInternational Journal of Behavioral Nutrition and Physical Activity, 2011
- British Thoracic Society guideline for non-CFbronchiectasisThorax, 2010
- Clinical determinants of the 6-Minute Walk Test in bronchiectasisRespiratory Medicine, 2009
- The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patientsInternational Journal of Rehabilitation Research, 2007
- Characterisation of the onset and presenting clinical features of adult bronchiectasisRespiratory Medicine, 2006
- A step test to assess exercise-related oxygen desaturation in interstitial lung diseaseEuropean Respiratory Journal, 2006
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax, 1999